Abstract:BACKGROUND:SKF83959 stimulates the phospholipase Cβ/inositol phosphate 3 pathway, resulting in the activation of Ca(2+)/calmodulin-dependent kinase IIα, which affects the synthesis of brain-derived neurotrophic factor, a neurotrophic factor critical for the pathophysiology of depression. Previous reports showed that SKF83959 elicited antidepressant activity in the forced swim test and tail suspension test as a novel triple reuptake inhibitor. However, there are no studies showing the effects of SKF83959 in a chronic stress model of depression and the role of phospholipase C/inositol phosphate 3/calmodulin-dependent kinase IIα/brain-derived neurotrophic factor pathway in SKF83959-mediated antidepressant effects.METHODS:In this study, SKF83959 was firstly investigated in the chronic social defeat stress model of depression. The changes in hippocampal neurogenesis, dendrite spine density, and brain-derived neurotrophic factor signaling pathway after chronic social defeat stress and SKF83959 treatment were then investigated. Pharmacological inhibitors and small interfering RNA/short hairpin RNA methods were further used to explore the antidepressive mechanisms of SKF83959.RESULTS:We found that SKF83959 produced antidepressant effects in the chronic social defeat stress model and also restored the chronic social defeat stress-induced decrease in hippocampal brain-derived neurotrophic factor signaling pathway, dendritic spine density, and neurogenesis. By using various inhibitors and siRNA/shRNA methods, we further demonstrated that the hippocampal dopamine D5 receptor, phospholipase C/inositol phosphate 3/ calmodulin-dependent kinase IIα pathway, and brain-derived neurotrophic factor system are all necessary for the SKF83959 effects.CONCLUSION:These results suggest that SKF83959 can be developed as a novel antidepressant and produces antidepressant effects via the hippocampal D5/ phospholipase C/inositol phosphate 3/calmodulin-dependent kinase IIα/brain-derived neurotrophic factor pathway.

SKF83959 Suppresses Excitatory Synaptic Transmission in Rat Hippocampus Via a Dopamine Receptor-Independent Mechanism.

The atypical dopamine receptor agonist SKF 83959 enhances hippocampal and prefrontal cortical neuronal network activity in a rat model of cognitive dysfunction

Activation of phosphatidylinositol-linked novel D1 dopamine receptors inhibits high-voltage-activated Ca2+ currents in primary cultured striatal neurons.

SKF82958, a dopamine D1 receptor agonist, disrupts prepulse inhibition in the medial prefrontal cortex and nucleus accumbens in C57BL/6J mice

Activation of the sigma receptor 1 suppresses NMDA responses in rat retinal ganglion cells

Arylbenzazepines Are Potent Modulators for the Delayed Rectifier K+ Channel: A Potential Mechanism for Their Neuroprotective Effects

Activation of Dopamine D1 Receptors Enhances the Temporal Summation and Excitability of Rat Retinal Ganglion Cells.

SKF83959 is a Potent Allosteric Modulator of Sigma-1 Receptor

SKF83959, an agonist of phosphatidylinositol-linked dopamine receptors, prevents renewal of extinguished conditioned fear and facilitates extinction

The Paradoxical Effects of Skf83959, A Novel Dopamine D-1-Like Receptor Agonist, in The-Rat Acoustic Startle Reflex Paradigm

The Ameliorative Effects and Underlying Mechanisms of Dopamine D1-like Receptor Agonist SKF38393 on Aβ1–42-induced Cognitive Impairment

Activation of the sigma receptor 1 modulates AMPA receptor-mediated light-evoked excitatory postsynaptic currents in rat retinal ganglion cells

SKF83959 Produces Antidepressant Effects in a Chronic Social Defeat Stress Model of Depression Through BDNF-TrkB Pathway.

SKF83959 is a Novel Triple Reuptake Inhibitor That Elicits Anti-Depressant Activity

Allosteric Modulation of Sigma‐1 Receptors by SKF83959 Inhibits Microglia‐mediated Inflammation

Allosteric Modulation of Sigma-1 Receptors Elicits Anti-Seizure Activities.

Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats

Activation of Phosphatidylinositol-linked Novel D 1 Dopamine Receptor Contributes to the Calcium Mobilization in Cultured Rat Prefrontal Cortical Astrocytes

Suppression of Outward K+ Currents by Activating Dopamine D1 Receptors in Rat Retinal Ganglion Cells Through PKA and CaMKII Signaling Pathways

The D₁ Dopamine Receptor Agonist, SKF83959, Attenuates Hydrogen Peroxide-Induced Injury in RGC-5 Cells Involving the Extracellular Signal-Regulated Kinase/p38 Pathways.

Inhibitory Effect of Dopamine on Ca(2+)-calmodulin-dependent Protein Kinase II Activity in Rat Hippocampal Slices.